Inotiv, Inc. Announces First Quarter Fiscal 2022 Financial Results

10.02.2022 - WEST LAFAYETTE, Ind., Feb. 10, 2022 (GLOBE NEWSWIRE) - Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development ...

Related Keywords

Colorado ,United States ,Seongnam ,Kyonggi Do ,South Korea ,Morrisville ,North Carolina ,Texas ,Betha Taylor ,Robert Leasure Jr ,Plato Biopharma ,Devin Sullivan ,Orient Bioresource Center Inc ,Equity Group Inc ,Bolder Biopath Inc ,Company Contact ,Synexa Life Sciences ,Nasdaq ,Accreditation Of Laboratory Animal Care ,Robinson Services Inc ,Gateway Pharmacology Laboratories ,Research Models ,Association For Assessment ,Plato Biopharma Inc ,Histotox Labs Inc ,Laboratory Systems ,Orient Bio Inc ,Holding Corp ,Exchange Commission ,Inotiv Inc ,Histotox Labs ,Envigo Equity Plan ,Robinson Services ,Integrated Laboratory Systems ,Laboratory Animal Care ,Orient Bioresource Center ,Orient Bio ,Incremental Term Loans ,Chief Executive Officer ,Synexa Life ,Life Sciences ,Through Envigo ,Gateway Pharmacology ,Operating Activities ,Chief Financial Officer ,Tables Follow ,